| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/03/2005 | CA2529405A1 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
| 02/03/2005 | CA2524184A1 Microbial cellulose wound dressing comprising phmb |
| 02/03/2005 | CA2499307A1 Treatment of heaves using r-(-)albuterol |
| 02/02/2005 | EP1502644A2 Combination of emulsifiers, emulsion containing the same and process for preparing the same. |
| 02/02/2005 | EP1502601A1 Use of neurotoxin therapy for treatment of urinary retention |
| 02/02/2005 | EP1502595A1 An injection made from ixeris sonchifolia for treatment of cardio-cerebral vascular disease and fundus diseases and method of producing thereof |
| 02/02/2005 | EP1502592A1 Controlled release oxycodone compositions |
| 02/02/2005 | EP1502591A2 Controlled-release formulations coated with aqueous dispersions of ethylcellulose |
| 02/02/2005 | EP1502588A1 Light-stabilized soft capsule for formulations |
| 02/02/2005 | EP1502587A1 Sustained release formulation for Venlafaxine hydrochloride |
| 02/02/2005 | EP1502586A1 Preparations for the application of anti-inflammatory agents |
| 02/02/2005 | EP1502581A1 Surfactant-free shaving composition |
| 02/02/2005 | EP1502020A2 Stackable low depth tray |
| 02/02/2005 | EP1501933A2 Reversible masking of liposomal complexes for targeted delivery |
| 02/02/2005 | EP1501771A1 Method of preparing porous calcium phosphate granules |
| 02/02/2005 | EP1501549A2 Lyophilised and liquid preparations comprising a polysaccharide derivative of camptothecin |
| 02/02/2005 | EP1501546A1 Stable pharmaceutical formulation for a combination of a statin and an ace inhibitor |
| 02/02/2005 | EP1501541A1 Encapsulated cells to elicit immune responses |
| 02/02/2005 | EP1501534A2 Desmopressin in an orodispersible dosage form |
| 02/02/2005 | EP1501521A1 Long acting compositions comprising zidovudine and lamivudine |
| 02/02/2005 | EP1501510A1 The treatment of pain with ifenprodil |
| 02/02/2005 | EP1501501A2 Method for oxygen treatment of unsaturated carbon compounds, novel epoxy-structured material obtained by the method, apparatus for carrying out the method and a therapeutic composition using the material |
| 02/02/2005 | EP1501500A2 Carvedilol formulations |
| 02/02/2005 | EP1501499A1 Trans-epicutaneous administration form for treating restless leg syndrome |
| 02/02/2005 | EP1501498A1 Pharmaceutical composition comprising a lipase inhibitor and glucomannan |
| 02/02/2005 | EP1501496A2 Formulations containing amiodarone and sulfoalkyl ether cyclodextrin |
| 02/02/2005 | EP1501493A1 Use of epa and dha in secondary prevention |
| 02/02/2005 | EP1501492A1 ANTI- i RHINOVIRUS /i ACTIVE AGENTS |
| 02/02/2005 | EP1501487A1 Capsule preparation |
| 02/02/2005 | EP1501486A1 Extended release tablets comprising felodipine |
| 02/02/2005 | EP1501485A1 High drug load tablet |
| 02/02/2005 | EP1501484A1 A process for the preparation of tablets from pharmaceutically active substances having unfavourable tabletting properties with a granulating liquid comprising microcrystalline cellulose |
| 02/02/2005 | EP1501483A2 Particulate materials |
| 02/02/2005 | EP1501482A1 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease |
| 02/02/2005 | EP1501481A2 Dispersions of lipids for use as therapeutic and cosmetic agents and intracellular delivery vehicles |
| 02/02/2005 | EP1501480A1 Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs |
| 02/02/2005 | EP1501479A1 Capsules for dry powder inhalers and methods of making and using same |
| 02/02/2005 | EP1501478A1 Warming and nonirritating anhydrous lubricant compositions |
| 02/02/2005 | EP1501477A2 Process for the treatment of particles for use in pharmaceutical formulations |
| 02/02/2005 | EP1501357A2 Use of vegf for treating bone defects |
| 02/02/2005 | EP1343512B1 Injectable solution with anti-inflammatory effect and process for manufacturing the same |
| 02/02/2005 | EP1235574B1 Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 02/02/2005 | EP1218009B1 Quetiapine granules |
| 02/02/2005 | EP1175390B1 Disodium salts, monohydrates, and ethanol solvates |
| 02/02/2005 | EP1165042B1 Drinkable ibuprofen pharmaceutical suspension |
| 02/02/2005 | EP1131104B1 Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester |
| 02/02/2005 | EP1130966B1 Antiparasitic formulations |
| 02/02/2005 | EP1061900B1 Dermal compositions |
| 02/02/2005 | EP1023077B1 Opthalmic composition |
| 02/02/2005 | EP1011688B1 Use of uridine 5'-diphosphate and analogs thereof for the treatment of lung diseases |
| 02/02/2005 | EP1007017B1 New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof |
| 02/02/2005 | EP0910339B1 Buccal polar spray |
| 02/02/2005 | EP0729357B1 Microencapsulated 1,2-benzazoles |
| 02/02/2005 | CN1575337A Mammalian receptor proteins; related reagents and methods |
| 02/02/2005 | CN1575299A Homing peptides |
| 02/02/2005 | CN1575292A Pharmaceutically acceptable salts of 20(s)-camptothecins |
| 02/02/2005 | CN1575186A Hard capsules based on polysaccharide and method for the production thereof |
| 02/02/2005 | CN1575181A Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders |
| 02/02/2005 | CN1575175A Drug formulation having improved oral tolerability |
| 02/02/2005 | CN1575170A (-)-1-(3, 4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 02/02/2005 | CN1575165A Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole |
| 02/02/2005 | CN1575164A Controlled release preparation of clarithromycin or tinidazole |
| 02/02/2005 | CN1575163A Granule formulation |
| 02/02/2005 | CN1575162A Combination dosage form containing a cholesterol -lowering agent , an inhibitor of the renin-angiotensin, and aspirin |
| 02/02/2005 | CN1575132A Process for preparing chewing gum containing a nutritional supplemental |
| 02/02/2005 | CN1572797A Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 02/02/2005 | CN1572316A Traditional Chinese medicine composition for treating diabetes |
| 02/02/2005 | CN1572315A Chinese patent medicines for treating chronic superficial gastritis (epigastric pain) and preparation method thereof |
| 02/02/2005 | CN1572314A Chinese patent medicine for treating apoplexy and its preparation method |
| 02/02/2005 | CN1572313A Chinese patent medicine for treating vaginal bleeding after medicinal abortion operation and its preparation method |
| 02/02/2005 | CN1572312A Chinese patent medicine for treating cardiac function failure and its preparation method |
| 02/02/2005 | CN1572311A Prepared licorice granule and its preparation method |
| 02/02/2005 | CN1572310A Chuanxiong rhizome volatile oil soft capsule and its preparation method |
| 02/02/2005 | CN1572309A Novel Chinese traditional medicine preparation of WuBei Powder for suspension and its preparation method |
| 02/02/2005 | CN1572303A Methods and compositions for the prevention of tolerance to medications |
| 02/02/2005 | CN1572302A Application of avermectin containing parasite resistant pharmaceutical solid dispersion |
| 02/02/2005 | CN1572301A Tylosin containing antibiotic injection for animals |
| 02/02/2005 | CN1572300A Avermectin containing parasite resisitant long-acting injectio |
| 02/02/2005 | CN1572297A Application of berberine tannic acid in the preparation process of acute/chronic pharyngitis treating medicine |
| 02/02/2005 | CN1572296A Freeze dried vinpocetine powder injection and its preparation process |
| 02/02/2005 | CN1572293A Legalon soft capsule and its preparing method |
| 02/02/2005 | CN1572153A Biological process for the production of a food product comprising heme-iron and food product obtained with said process |
| 02/02/2005 | CN1572148A Hard dragee-coating process |
| 02/02/2005 | CN1187318C Solid composition suitable for oral administration comprising non hydroscopic salts of L-carnitine or alkanoyl-L-carnitine with 2-aminoethanesulfonic acid |
| 02/02/2005 | CN1187312C Amorphous compounds and their pharmaceutical compositions |
| 02/02/2005 | CN1187106C Dual adhesive transdermal drug delivery system |
| 02/02/2005 | CN1187103C Syringe and capsule therefor |
| 02/02/2005 | CN1187095C Encapsulated cells capable of producing viral particles |
| 02/02/2005 | CN1187093C Composition for inhalation comprising delta-9-tetrahydrocannabinol in semiaqueous solvent |
| 02/02/2005 | CN1187089C Application of photosensitizer in preparing medicine for lightening and preventing inflammation of damnified tissue |
| 02/02/2005 | CN1187083C Method for producing Huafenliuwei pill |
| 02/02/2005 | CN1187082C Chinese medicine powder inhalant for curing asthma, its preparation method and application |
| 02/02/2005 | CN1187079C Auxiliary medicine for cancer and preparation thereof |
| 02/02/2005 | CN1187075C Preparation method of fresh gastrodia whole powder |
| 02/02/2005 | CN1187072C Medicine composition for treating gynaecology inflammation and its preparation method |
| 02/02/2005 | CN1187070C Suppository for treating piles and other anorectal diseases and its preparation method |
| 02/02/2005 | CN1187065C Ointment for treating dermatopathy and preparing process thereof |
| 02/02/2005 | CN1187064C Medicine for treating epidemic hemorrhagic fever |
| 02/02/2005 | CN1187060C Extracts of shark cartilage, its preparation method and usage |
| 02/02/2005 | CN1187057C Trivalent cerium carried rectorite anti-inflammatory and bacteriostatic medicine and preparation process thereof |